Literature DB >> 23340992

Time trends and disparities in lymphadenectomy for gastrointestinal cancer in the United States: a population-based analysis of 326,243 patients.

A Dubecz1, N Solymosi, M Schweigert, R J Stadlhuber, J H Peters, D Ofner, H J Stein.   

Abstract

BACKGROUND: The value of lymphadenectomy in most localized gastrointestinal (GI) malignancies is well established. Our objectives were to evaluate the time trends of lymphadenectomy in GI cancer and identify factors associated with inadequate lymphadenectomy in a large population-based sample.
METHODS: Using the National Cancer Institute's Surveillance Epidemiology and End Results Database (1998-2009), a total of 326,243 patients with surgically treated GI malignancy (esophagus, 13,165; stomach, 18,858; small bowel, 7,666; colon, 232,345; rectum, 42,338; pancreas, 12,141) were identified. Adequate lymphadenectomy was defined based on the National Cancer Center Network's recommendations as more than 15 esophagus, 15 stomach, 12 small bowel, 12 colon, 12 rectum, and 15 pancreas. The median number of lymph nodes removed and the prevalence of adequate and/or no lymphadenectomy for each cancer type were assessed and trended over the ten study years. Multivariate logistic regression was employed to identify factors predicting adequate lymphadenectomy.
RESULTS: The median number of excised nodes improved over the decade of study in all types of cancer: esophagus, from 7 to 13; stomach, 8-12; small bowel, 2-7; colon, 9-16; rectum, 8-13; and pancreas, 7-13. Furthermore, the percentage of patients with an adequate lymphadenectomy (49 % for all types) steadily increased, and those with zero nodes removed (6 % for all types) steadily decreased in all types of cancer, although both remained far from ideal. By 2009, the percentages of patients with adequate lymphadenectomy were 43 % for esophagus, 42 % for stomach, 35 % for small intestine, 77 % for colon, 61 % for rectum, and 42 % for pancreas. Men, patients >65 years old, or those undergoing surgical therapy earlier in the study period and living in areas with high poverty rates were significantly less likely to receive adequate lymphadenectomy (all p < 0.0001).
CONCLUSIONS: Lymph node retrieval during surgery for GI cancer remains inadequate in a large proportion of patients in the USA, although the median number of resected nodes increased over the last 10 years. Gender and socioeconomic disparities in receiving adequate lymphadenectomy were observed.

Entities:  

Mesh:

Year:  2013        PMID: 23340992     DOI: 10.1007/s11605-013-2146-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  47 in total

1.  Surgical resection for locoregional esophageal cancer is underutilized in the United States.

Authors:  Attila Dubecz; Boris Sepesi; Renato Salvador; Marek Polomsky; Thomas J Watson; Daniel P Raymond; Carolyn E Jones; Virginia R Litle; Juan P Wisnivesky; Jeffrey H Peters
Journal:  J Am Coll Surg       Date:  2010-10-25       Impact factor: 6.113

2.  Pancreatic cancer in the general population: Improvements in survival over the last decade.

Authors:  Taylor S Riall; William H Nealon; James S Goodwin; Dong Zhang; Yong-Fang Kuo; Courtney M Townsend; Jean L Freeman
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).

Authors:  L P Fielding; P A Arsenault; P H Chapuis; O Dent; B Gathright; J D Hardcastle; P Hermanek; J R Jass; R C Newland
Journal:  J Gastroenterol Hepatol       Date:  1991 Jul-Aug       Impact factor: 4.029

Review 4.  A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer.

Authors:  Savtaj S Brar; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-09-14       Impact factor: 7.370

5.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

Authors:  Jin-Pok Kim; Joo-Ho Lee; Soo-Jin Kim; Hang-Jong Yu; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  1998-03       Impact factor: 7.370

6.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.

Authors:  Taylor S Riall; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

Review 7.  What is the effect of age on pancreatic resection?

Authors:  Taylor S Riall
Journal:  Adv Surg       Date:  2009

8.  Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.

Authors:  Anne Le; David Berger; Melvin Lau; Hashem B El-Serag
Journal:  Ann Surg Oncol       Date:  2007-07-03       Impact factor: 5.344

9.  Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Authors:  Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Juan P Wisnivesky
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  8 in total

1.  Extended lymphadenectomy in colon cancer is crucial.

Authors:  Hermann Kessler; Werner Hohenberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

2.  Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas.

Authors:  A Calero; J Escrig-Sos; F Mingol; A Arroyo; D Martinez-Ramos; M de Juan; J L Salvador-Sanchis; E Garcia-Granero; R Calpena; F J Lacueva
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

3.  Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA.

Authors:  Anthony M Villano; Alexander Zeymo; James McDermott; Andrew Crocker; Jay Zeck; Kitty S Chan; Nawar Shara; Sunnie Kim; Waddah B Al-Refaie
Journal:  J Gastrointest Surg       Date:  2019-02-20       Impact factor: 3.452

Review 4.  Non-surgical factors influencing lymph node yield in colon cancer.

Authors:  Patrick Wood; Colin Peirce; Jurgen Mulsow
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

5.  Sentinel lymph node biopsy for papillary thyroid cancer: the effect of dose, tracer and application of massage.

Authors:  Abbas Alibakhshi; Saeed Farzanehfar; Mahya Zarei; Mohammad Eftekhari; Maziar Motiee; Maryam Naseri; Mehrshad Abbasi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021

6.  Application of Contrast-Enhanced Ultrasound (CEUS) in Lymphomatous Lymph Nodes: A Comparison between PET/CT and Contrast-Enhanced CT.

Authors:  Xuelei Ma; Wenwu Ling; Fan Xia; Yifan Zhang; Chenjing Zhu; Jialing He
Journal:  Contrast Media Mol Imaging       Date:  2019-01-23       Impact factor: 3.161

7.  Has the increase in the regional nodes evaluated improved survival rates for patients with locoregional colon cancer?

Authors:  Zhongyi Zhou; Hong Zhu; Wenxue Liu; Fengbo Tan; Qian Pei; Lilan Zhao; Chenglong Li; Dan Wang; Yuan Zhou; Huan Peng; Haiping Pei; Yuqiang Li
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

8.  Colon cancer care and survival: income and insurance are more predictive in the USA, community primary care physician supply more so in Canada.

Authors:  Kevin M Gorey; Sindu M Kanjeekal; Frances C Wright; Caroline Hamm; Isaac N Luginaah; Emma Bartfay; Guangyong Zou; Eric J Holowaty; Nancy L Richter
Journal:  Int J Equity Health       Date:  2015-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.